Effects of Sustamine(TM) on Cycling Time Trial Performance

The University of Texas System (UT)

Status: Unknown

Conditions: Healthy

Treatments: Dietary Supplement: Placebo Beverage; Dietary Supplement: 19.6 g Sustamine Beverage; Dietary Supplement: 2.8 g Sustamine Beverage

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT01623947

2012-03-0043

Details and patient eligibility

About

Acute supplementation of Sustamine(TM), a combination of two amino acids, will improve cycling performance and mental acuity in a dose-dependent response.

Enrollment: 14 estimated patients

Sex: All

Ages: 20 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Competitive cyclist or triathlete
• Male (VO2max >= 55 ml/kg/min) or Female (VO2max >= 45 ml/kg/min)
• Healthy
• Blood pressure below 140/90
• Non-smoker

Exclusion criteria

• Anti-depressant medications
• Inconsistent regular medications
• Consumption performance-enhancing substances
• Type I or Type II diabetes
• Renal, hepatic or cardiac disease Current infectious disease

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Triple Blind

---

14 participants in 3 patient groups, including a placebo group

Placebo

Placebo Comparator group

Treatment:

Dietary Supplement: Placebo Beverage

2.8 g Sustamine

Active Comparator group

Treatment:

Dietary Supplement: 2.8 g Sustamine Beverage

19.6 g Sustamine

Active Comparator group

Treatment:

Dietary Supplement: 19.6 g Sustamine Beverage